A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Clinical trial NCT05849662 · RECRUITING
Trial details
- NCT number
- NCT05849662
- Sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-11
- Primary completion
- 2028-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.